Century Therapeutics to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Rhea-AI Summary

Century Therapeutics (NASDAQ: IPSC) announced the participation of its senior management in a fireside chat ahead of the Piper Sandler 33rd Annual Virtual Healthcare Conference, scheduled for November 30 to December 2, 2021. A recording of the chat will be available today at 10:00 AM ET on the Events & Presentations section of Century's website, accessible for 30 days. The company focuses on developing iPSC-derived cell therapies aimed at overcoming challenges in cancer treatment.

PHILADELPHIA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that members of the senior management team have participated in a fireside chat in advance of the Piper Sandler 33^rd Annual Virtual Healthcare Conference, being held November 30- December 2, 2021.

A recording of the fireside chat will be available today at 10:00 AM ET on the Events & Presentations section of Century’s website and will be available for 30 days.

About Century Therapeutics

Century Therapeutics, Inc. (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK and iT cell product candidates are designed to specifically target hematologic and solid tumor cancers. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of cancer care. For more information on Century Therapeutics please visit www.centurytx.com.

Century Therapeutics Forward-Looking Statement

This press release contains forward-looking statements within the meaning of, and made pursuant to the safe harbor provisions of, The Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as “may,” “might,” “will,” “should,” “expect,” “plan,” “aim,” “seek,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “forecast,” “potential” or “continue” or the negative of these terms or other similar expressions. These statements are not guarantees of future performance These risks and uncertainties are described more fully in the “Risk Factors” section of our most recent filings with the Securities and Exchange Commission and available at www.sec.gov. You should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

For More Information:
Company: Elizabeth Krutoholow – investor.relations@centurytx.com
Investors: Melissa Forst/Maghan Meyers – century@argotpartners.com
Media: Joshua R. Mansbach – century@argotpartners.com

FAQ

What is Century Therapeutics's focus in biotechnology?

Century Therapeutics specializes in developing iPSC-derived cell therapies for cancer treatment, emphasizing immuno-oncology.

When is the Piper Sandler healthcare conference taking place?

The Piper Sandler 33rd Annual Virtual Healthcare Conference is scheduled from November 30 to December 2, 2021.

How can I access the fireside chat recording from Century Therapeutics?

The recording of the fireside chat will be available at 10:00 AM ET on November 22, 2021, on Century's website under Events & Presentations for 30 days.

What are the potential benefits of Century Therapeutics's cell therapies?

Century's iPSC-derived therapies are designed to overcome limitations of first-generation cell therapies, with a focus on increased patient access and targeted cancer treatment.

What is the significance of iPSC in Century Therapeutics's product development?

Induced pluripotent stem cells (iPSC) are crucial for Century's product candidates as they allow for the development of off-the-shelf cell therapies targeting various cancers.